R.V. Paul Chan, MD, MSc, MBA is the Department Head and the John H. Panton, MD Professor of Ophthalmology at the Illinois Eye and Ear Infirmary, University of Illinois at Chicago (UIC). He is the Co-Director of the Vitreoretinal Fellowship and serves as Director of the Pediatric Retina and Retinopathy of Prematurity (ROP) Service. His clinical practice focuses on vitreoretinal surgery, with an expertise in pediatric retinal disease. Dr. Chan received his BA from the University of Pennsylvania, MD from the Temple University School of Medicine, MSc from Weill Cornell Medical College (WCMC), and MBA from the University of Chicago’s Booth School of Business. After completing Ophthalmology residency at the New York-Presbyterian Hospital of WCMC, he went on to a Fellowship in Vitreoretinal Surgery at the Massachusetts Eye and Ear Infirmary at Harvard Medical School. Dr. Chan spent nine years on faculty at WCMC, as Director of the Retina Service and Vitreoretinal Fellowship, before moving to UIC.
Dr. Chan previously served as the Vice Chair for both Clinical Affairs and Global Ophthalmology in the Department of Ophthalmology and Visual Sciences at UIC and is a global leader in pediatric blindness prevention and ROP. His primary research interests focus on utilizing new technology and imaging techniques to better evaluate and manage children with retinal disease. He has authored over 160 peer reviewed articles and has received grant funding by the NIH, the NSF, and a number of charitable foundations. He is a core team member of the Imaging and Informatics for ROP (i-ROP) consortium and leads the Global Education Network for ROP (GEN-ROP), which is an international collaboration of investigators with expertise in neonatology, ophthalmology, biomedical informatics, international health, and medical education. Together, they have developed tele-education and telemedicine programs, and have established clinical, teaching, and research collaborations in Asia, Latin America, and Africa. Dr. Chan also serves as a consultant for programs sponsored by the United States Agency for International Development (USAID), Orbis International, and Helen Keller International (HKI).
Dr. Chan has been very actively involved in academic ophthalmology and organized medicine. He serves on the Board of Trustees for HKI, the Executive Committee for the Pan-American Association of Ophthalmology (PAAO), and the Committee of Secretaries for the American Academy of Ophthalmology (AAO), where he is the Secretary for Global Alliances. Dr. Chan is an assistant editor for the journal, Retina, and is on the editorial board for Retina Today, Ocular Surgery News, the Journal of Pediatric Ophthalmology and Strabismus, the Asia-Pacific Journal of Ophthalmology, and the Journal of VitreoRetinal Diseases. He is an active member in a number of ophthalmic societies, including the American Ophthalmological Society, the Club Jules Gonin, the Retina Society, the Macula Society, founding member of the Vit-Buckle Society, the Association of Pediatric Retina Surgeons, the American Society of Retina Specialists, and he is Past President of the Chinese American Ophthalmological Society and Past President of the American Eye Study Club. He has also served on the Global ONE Advisory Board and the Ethics Committee for the AAO.
Dr. Fawzi is a vitreoretinal surgeon and clinician-scientist, Professor in the Department of Ophthalmology. She holds the Cyrus Tang and Lee Jampol endowed Professorship and divides her time between her clinical/surgical practice and her NIH-Funded research at Northwestern University.
At Northwestern University, Dr. Fawzi runs an active NIH-funded translational research laboratory. Her lab studies animal models of ischemic retinopathies and her clinical research focuses on novel functional retinal imaging approaches including OCT angiography and Adaptive Optics. Recognized for her imaging research, Dr. Fawzi serves on the Editorial Boards of Scientific Reports (Nature), Retina Journal and Investigative Ophthalmology and Visual Sciences, as well as serving on several NIH study sections. She has authored/coauthored over 200 peer-reviewed articles, has delivered several named Lectureships and has been elected as member of the Retina and Macula Societies. She has received the Honor Award of the American Society of Retina Specialists, the Young Investigator Award of the Macula Society, the Secretariat and the Achievement Awards of the American Academy of Ophthalmology and is a Silver Fellow of the Association of Research in Vision and Ophthalmology.
Robyn Guymer is Professor of Ophthalmology at Melbourne University and a deputy director of the Centre for Eye Research Australia. She is also a senior retinal specialist at the Royal Victorian Eye and Ear Hospital. She is a clinician scientist who leads a team of researchers primarily investigating Age related macular degeneration (AMD) and has co-authored over 300 peer reviewed papers. She is currently investigating new strategies for treating early stages of AMD and is working to identify novel imaging and functional biomarkers and surrogate endpoints to improve the feasibility of conducting early intervention trials. She has been a principal investigator in many industry sponsored trials, serves on several pharmaceutical advisory boards and is a member of several international working groups on macular diseases. She is an inaugural fellow of the Australian Academy of Health and Medical Sciences. In June 2018 she was awarded the Member of the Order of Australia for significant service to medicine in the field of ophthalmology, particularly age related macular degeneration as a clinician, academic and researcher. In 2020 she spent a year in Switzerland as the first visiting professor in Ophthalmology to La Hoffmann Roche, a large pharmaceutical company, to better understand and facilitate academic/industry collaborations.
Michael S. Ip, MD, is Professor, Department of Ophthalmology at the David Geffen School of Medicine at the University of California - Los Angeles. He is a member of the Doheny Eye Institute and currently serves as the Medical Director of the Doheny Image Reading Center. Prior to June 2016, Dr. Ip was on faculty at the University of Wisconsin School of Medicine and Public Health in Madison, WI and was a co-director of the Fundus Photograph Reading Center at the University of Wisconsin. He also served as Director of the Retina Service at the William S. Middleton Memorial Veterans Hospital in Madison, WI. Dr. Ip received his medical degree from New York University and completed his internship at Lenox Hill Hospital, both in New York, New York. He completed his residency at the University of Pittsburgh School of Medicine in Pennsylvania followed by a fellowship in vitreoretinal surgery at the New England Eye Center, Tufts University, in Boston, Massachusetts.
Dr. Ip’s research focuses on the design and conduct of clinical trials investigating treatments for diabetic retinopathy, AMD, and retinal venous occlusive disease. Previously as Co-Director of the Fundus Photograph Reading Center, he has assisted with the collection, analysis, and dissemination of important secondary outcomes in numerous industry and NIH-funded ophthalmic clinical trials. As a clinical site investigator, he has served as the Principal Investigator on over 17 clinical trials. He has also served as the protocol chair for the clinical trial conducted by the Diabetic Retinopathy Clinical Research Network (DRCR.net) comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema and as the National Principal Investigator for the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study. In 2003, Dr. Ip and colleagues received an award from the NEI to conduct the SCORE Study. In 2013, this group received funding from the NEI to conduct the SCORE2 Study. This avenue of research continues in his role as the Medical Director of the Doheny Image Reading Center.
He has authored more than 120 peer-reviewed articles, 25 book chapters, and more than 70 abstracts on these topics as well as has given many national and international presentations. Dr. Ip is also a reviewer for the following six journals: Ophthalmic Surgery and Lasers, Investigative Ophthalmology and Visual Science, American Journal of Ophthalmology, Retina, and Ophthalmology. He is as well a former Associate Editor for Archives of Ophthalmology. Furthermore, Dr. Ip has been recognized with several honors, including the Senior Achievement Award and the Leadership Development Program Award, both from the American Academy of Ophthalmology.
Anat Loewenstein, MD, Professor of Ophthalmology, Vice Dean of the Faculty of Medicine, and Sidney Fox Chair of Ophthalmology at the Sackler Faculty of Medicine at the Tel Aviv University, and the Chairman of the Division of Ophthalmology at the Tel Aviv Medical Center. Dr Loewenstein studied medicine at the Hebrew University in Jerusalem. Following that, was 4 years in the Israeli Navy, completed residency in the Department of Ophthalmology at the Tel Aviv Medical Center in Tel Aviv, and fellowship in retina vascular diseases and vitreoretina surgery unit at the Wilmer Institute, at Johns Hopkins University Hospital in Baltimore, Maryland.
Following this, returned to Israel and after 2 years as the Head of the Vitreoretinal Unit, became the Chairman of the Department of Ophthalmology at the Tel Aviv Medical Center. Completed also a Master of Health Administration degree at the Tel Aviv University Business School.
Main field of interest is the investigation of the drug administration and toxicity to the retina, early detection of macular degeneration and home monitoring of disease. Involved in the development of multiple innovative efforts, was the leader behind the development of novel technology for early detection of macular degeneration, the development of automated technology for detection of retinal disease activity and the development of augmented virtual reality to replace the operating microscope as well as development of home OCT.
Published 400 papers in peer reviewed journals, and contributed multiple chapters to ophthalmology textbooks.
Has multiple roles in the most prominent retina societies. Today, serves on the International committee of the macula society and is currently the General Secretary of the Euretina.
Is active at most international retina meetings and is an invited speaker in most.
Serves as the Editor in Chief of the Journal Case Reports in Ophthalmology, is an associate editor of the European Journal of Ophthalmology and of Ophthalmologica.
In Israel, serves as the president of the Israeli Ophthalmological Society and as chair of the Ministry of Health's ethics committee. In addition, is a member of the National Council of Surgery and anesthesia.
Received multiple international awards, including the “Rosenthal” award, and the Patz medal of the Macula Society, as well as the Michelson Award of the Macula Society, and the Silver Fellow Medal of ARVO.
Is a leader in retina disease diagnosis and management and serves on the medical advisory boards of most prominent ophthalmological pharma and device companies.
Has many roles as a leader in mentorship of young retina specialists including a mentorship educational program of ARVO, Euretina as well as mentorship programs supported by industry.
Dr. Dante J. Pieramici graduated with honors from the Johns Hopkins University School of Medicine and completed Ophthalmology Residency at the Wilmer Eye Institute. He received his vitreoretinal fellowship training at the Emory Eye Center in Atlanta, Georgia. Dr. Pieramici has held full-time academic positions at the Yale University Eye Center and the Wilmer Eye Institute, where he served as the Assistant Chief of Service and Director of Ocular Trauma. Currently he is the Director of the California Retina Research Foundation, and a partner of the California Retina Consultants and serves on the leadership board of the Retina Consultants of America.
Dr. Pieramici has published over 125 peer reviewed papers, 16 book chapters, and has edited 3 books on retinal diseases. He lectures nationally and internationally on retinal diseases and ocular trauma. He has longed served as section editor for the Retina Times.
Dr. Pieramici’s research interests are varied, and include clinical and basic science projects aimed at a better understanding of the underlying pathophysiology of ocular diseases, so as to improve treatments for patients with age-related macular degeneration, diabetic retinopathy, retinal vascular diseases, and severe ocular injuries. He has been a clinical investigator, principal investigator, or reading center investigator on hundreds of NIH, investigator initiated, and pharmaceutical company sponsored clinical trials. He has served on the steering and advisory committee for a number of multicenter phase 3 clinical trials. Dr. Pieramici has helped in the development of new surgical techniques including limited macular translocation, 25-gauge vitrectomy surgery, the Port Delivery System, and retinal disease applications of gene therapy.
Dr. Pieramici has received the Achievement Award from the American Academy of Ophthalmology and Senior Honor Award from the American Society of Retinal Specialists. He is a member of the American Academy of Ophthalmology, the Retina Society, the Macula Society, the American Society of Retinal Specialists, The Association for Research in Vision and Ophthalmology, the American Society of Ocular Trauma where he served as Vice President, and the Pan-American Ophthalmologic Society amongst others. Dr. Pieramici is a board member of S.E.E. International and regularly trains international ophthalmologists from underserved areas. He also served as board member and president of the Santa Barbara County Medical Society.
Dr. Sohn is Associate Professor and Director of Retina Fellowships at the University of Iowa. He engages in basic, translational and clinical research related to retinal diseases, especially (1) age-related macular degeneration: basic mechanisms of causes especially related to genetics and the choroid; clinical trials; and development of novel therapies for AMD-related vision loss (2) diabetic retinopathy: tissue and image-based analysis in mice and humans with focus on pathophysiology and treatment (3) vitreoretinal disorders and innovations to improve retinal surgery, (4) inherited macular dystrophies and retinal degenerations: genotype-phenotype correlations and development of tools and procedures for gene and stem cell therapies to treat retinal and macular degenerations.
His lab is funded by the NIH and he has served as PI of multiple clinical trials for AMD treatments and was a surgeon/sub-investigator in the successful phase III trial using gene therapy to treat RPE65-associated retinitis pigmentosa/leber congenital amaurosis, leading to the first gene therapy treatment to be approved by the FDA (voretigene neparvovec-rzyl). He is an internationally recognized key opinion leader in retinal gene and stem cell therapies.
Dr. Sohn is active in leadership roles for education, advocacy, and research in his field. He serves on the Accreditation Council for Graduate Medical Education Residency Review Committee and committees for the American Academy of Ophthalmology (AAO), Retina Society, Association for Research in Vision and Ophthalmology (ARVO), American Society of Retina Specialists, and the Executive Committee of the Macula Society. He served ARVO as Chair of the Retina section of the Annual Meeting Program Committee; AAO, Asia Pacific Academy of Ophthalmology and Asia Pacific Vitreoretinal Society as subcommittee reviewer (retina-vitreous) for the Annual Meeting Program Committees. He is a founding member of the University of Iowa’s Institute for Vision Research.
He has written or co-authored over 80 peer-reviewed manuscripts and 10 book chapters, and serves as Associate Editor for the AAO Basic Techniques of Ophthalmic Surgery textbook. He is on the editorial board of Nature Scientific Reports and the Asia Pacific Journal of Ophthalmology. He has been voted numerous times as one of the 'Best Doctors in America' and is the recipient of the AAO Achievement Award, ASRS Honor Award, Eugene de Juan Award for Innovation, the Ophthalmologists Top 40 under 40 worldwide, and inducted to the Olympia High School Hall of Fame. He has given over 100 talks throughout the world on his research including invited and endowed award lectures on broad topics ranging from retinal diseases and surgery to work-life balance.
Richard F. Spaide, MD is a specialist in retinal diseases and has published more than 300 articles in peer-reviewed journals, more than 50 book chapters, and edited several books. He is a graduate of Muhlenberg College and Jefferson Medical College in Philadelphia. He completed his Ophthalmology Residency at St. Vincent's Hospital and Medical Center in New York and his Retina Fellowship at the Manhattan Eye, Ear, and Throat Hospital. His major research interests include macular diseases, retinal surgery, and ocular imaging.
Past highlights in his published papers include indocyanine angiography, fundus autofluorescence, characterization of central serous chorioretinopathy, application of mechanical engineering principles to macular hole formation, development of concepts concerning oxidative damage and characterization of lipid peroxides in Bruch's membrane, the combination of photodynamic therapy and intravitreal triamcinolone for age-related macular degeneration, and development of new methodologies to image the retina and choroid. His current research interests include multimodal imaging, optical coherence tomography angiography, and new computer-based rendering techniques to visualize retinal anatomy.
Dr. Spaide has been cited in multiple Who's Who and Best Doctors lists and has received many awards including the Richard and Linda Rosenthal Foundation Award in the Visual Sciences, Prix Soubrane de la Recherche en Ophthalmologie, Award of Merit from the Retina Society, Henkind Award, Coscas Award, Nataraja Pillai Award from the Vitreoretinal Society of India, W. Richard Green MD Award, George Theodossiadis Award from the Greek Retinal Society, Founders Award from the American Society of Retinal Surgeons, Life Achievement Honor Award from the American Academy of Ophthalmology, the Simon Gratz Award from Thomas Jefferson University, Roger Johnson Memorial Award for Macular Degeneration Research, J. Donald Gass Award, and the Doyne Medal. He is a Fellow of the Association for Research and Vision in Ophthalmology. He is on the Editorial Board of several journals, an Associate Editor of the journal Retina. In a recent publication by John Ioannidis, MD, D Sc recently published a study of the impact of publications by nearly 7 million scientists around the globe and Richard Spaide was ranked in the top 0.01%.
Professor David Steel is a Consultant Vitreoretinal Surgeon at Sunderland Eye Infirmary, as well as Honorary Professor of Retinal Surgery at the Bioscience Institute at Newcastle University and Visiting Professor of Ophthalmology at the University of Liverpool. He has research interest in many aspects of retinal disease, has published over 200 peer reviewed publications with over 8500 citations with an H index of 42, and was named as the UK NIHR and Royal College of Ophthalmologists Researcher of the year award in 2018. He is Associate Editor for the Royal College of Ophthalmologist’s Journal Eye, and on the editorial board of several international Ophthalmic journals. He is President of the British and Eire Association of Vitreoretinal Surgeons and an elected member and Executive Board member of the Club Jules Gonin. He has been invited Guest speaker at several National and International retinal meetings.
Ramin Tadayoni, MD, PhD, is Professor of Ophthalmology at the Université de Paris, and Department Chairman at Lariboisière, Saint Louis and Rothschild Foundation Hospitals, Paris, France. He is also the leader of French government funded RHU EviRed research program on artificial intelligence for diabetic retinopathy. He is EURETINA President Elect, past President of the French-speaking Retina Specialists Society (CFSR), and since 2017 elected as associate of the French “Académie Nationale de Chirurgie”.
His main areas of interest include retinal diseases, vitreoretinal surgery, and imaging. He is the author of over 180 peer-reviewed medical and scientific articles and has made numerous contributions to ophthalmology textbooks. He has been an invited lecturer for many society meetings and was awarded the American Academy of Ophthalmology Achievement Award in 2010.
Professor Tadayoni was graduated as medical doctor and ophthalmologist from Paris V University. He completed his vitreoretinal fellowship at Lariboisière University Hospital, Paris. He also pursued his PhD at Paris VII University, and Paris Vision Institute. He was later awarded HDR, the highest academic degree in France. He is very committed to education and has the honour of having trained several clinical vitreoretinal and research fellows.
Dr. Wykoff is Director of Research at Retina Consultants of Texas and Chairman of Research & Clinical Trials, Retina Consultants of America. He received his baccalaureate from MIT, PhD from Oxford University, MD from Harvard Medical School, and completed retina training at Bascom Palmer Eye Institute. He is passionate about translational research and clinical trial design and has published over 200 peer-reviewed manuscripts.
Dr. Wykoff serves on multiple scientific and medical advisory boards, safety monitoring committees, and global steering committees for endeavors spanning the innovative process from early to late stage developments. He is President of the Vit-Buckle Society, serves on the ASRS Board of Directors, and is also a founding member of the Ophthalmology Retina Editorial Board. He has been awarded multiple Achievement and Honor Awards along with the ASRS Young Investigator and the AAO Secretariat Awards.
Dr. Chaudhary is Professor of Surgery and Chief of Ophthalmology at McMaster University. He is an Associate Member at McMaster School of Biomedical Engineering and McMaster Department of Health Research Methods, Evidence & Impact.
He is passionate about translational research and evidence generation & synthesis in retina. He serves on multiple clinical and medical advisory boards and global steering committees for retina endeavors spanning from basic science research to multi-national clinical trials in the field of retina. He is co-chair of the Canadian Retina Research Network (CR2N). He is very interested in knowledge translation and serves as CPD Director for the Canadian Retina Society and CPD council member for the Canadian Ophthalmological Society. He was appointed Editor-in-Chief for the Canadian Journal of Ophthalmology in 2018. He has been awarded multiple Education, Achievement and Research Awards along with the Honor and Senior Honor Award by the American Society of Retinal Specialists.
Dr Gizicki received his medical degree from McGill University and completed his residency in ophthalmology at the Université de Montréal, Québec. He then went on to complete a 2-year sub-specialty training in vitreo-retinal diseases and surgery at St Michael’s Hospital, University of Toronto, Canada. He then joined the retina group at Retina Surgical Associates and the Department of Ophthalmology at the University of British Columbia.
His interests are diverse and include retinal detachment repair, diabetic retinopathy treatment, complications of cataract surgery, retinopathy of prematurity, and surgical performance analysis and benchmarking.
He is board-certified with the Royal College of Surgeons and Physicians of Canada as well as with the American Board of Ophthalmology. He is a member of many professional societies including the BC Society of Eye Physicians and Surgeons, Canadian Retina Society, American Society of Retina Specialists.
Dr Noble is a medical retina specialist and assistant professor at the University of Toronto, Department of Ophthalmology and Vision Sciences. He attended the University of Toronto for his residency training and then pursued fellowship in medical retina and diabetic eye disease at the Beetham Eye Institute at the Joslin Diabetes Center, Department of Ophthalmology, Harvard Medical School. He is board certified in Canada and the USA and works in private practice and also as a consultant at Sunnybrook Health Sciences Center and Markham-Stouffville Hospital. Dr Noble is actively involved in medical education and clinical research.
Cynthia X. Qian is currently a professor in the Department of Ophthalmology and the head of the electrophysiology laboratory and the pediatric retina service at the University of Montreal.
Dr. Qian completed medical school at McGill University. She then went on to finish residency at the University of Montreal where she was chief resident and graduated as the school valedictorian. During this time, she was a Rhodes Scholar finalist for the Province of Quebec and also received the Forces Avenir Personality of the Year award for her implication in International Medicine and Volunteer work.
She received the CNIB EA Baker Fellowship Award and the Besner Valois Fellowship Award and completed dual fellowships in surgical retina at the Massachusetts Eye and Ear Infirmary at Harvard Medical School in Boston and in inherited retinal diseases at the Kellogg Eye Center, University of Michigan respectively.
She is the current Vice President of the Canadian Retina Society, the chair of Royal College Retina AFC committee, and the provincial representative for Quebec in Ophthalmology at the Royal College of Physicians and Surgeons of Canada. She is a fellow of the Royal College of Physicians and Surgeons of Canada and of the American Academy of Ophthalmology (AAO), and a member of the Canadian Ophthalmological Society (COS), AAO, the American Society of Retina Specialists, ARVO, and PAAO.
Her main research interest is in clinical trials on new therapies in inherited retinal diseases. She is an expert on pathologies of the pediatric retina and on retinal dystrophy. She is the first university-designated clinician-scientist in the department of Ophthalmology in over ten years.
She is an official spokesperson for the Canadian Ophthalmological Society. She has been recognized for her ground-breaking work both as a leader in medicine and in clinical ophthalmology. She was chosen as the Young Physician delegate representing Canada at the Young Physician Leaders forum at the World Health Summit in Berlin in 2017. She has also been voted as “The Young Professional of the Year” by the Young Chamber of Commerce of Montreal in 2018 and as one of Canada’s Top 40 under 40 in 2019 and was one of the speakers chosen to present her work at the inaugural University of Montreal TEDx Ophthalmology event in 2021.